Answers are grounded in this paper and cite their sources.
Green synthesis enhances antibacterial activity of nanocomposites in drug-resistant bacteria, suggesting new biomedical uses.
Green synthesis of antimicrobial nanocomposites (NCs) offers a promising strategy to combat drug-resistant bacteria, a growing global health threat. In this work, we report the first-time green synthesis of CuO/TiO 2 @Chitosan NCs using Matricaria chamomilla extract, uniquely combining phytochemicals and a natural biopolymer in a single-step biosynthesis. An anthrone assay confirms that CuO/TiO 2 NC stability is due to carbohydrates, while the interaction of NCs with chitosan causes increased carbohydrate content. The addition of chitosan to CuO/TiO 2 NC increased their antioxidant activity and antibacterial efficacy. CuO/TiO 2 @Cs NC showed excellent antibacterial activity against E. coli , S. typhimurium , B. cereus , S. aureus , and S. epidermidis bacteria, and the results were between 12.0 ± 1.27 mm and 19.0 ± 1.60 mm. The antibacterial findings, on the other hand, confirmed that M. chamomilla extract and CuO/TiO 2 NC were not effective in inhibiting the growth of the bacterial strains. In addition, a molecular docking study was conducted to assess the interaction among phytochemicals of M. chamomilla with bacterial targets. Compared to similar nanocomposites in the literature, the CuO/TiO 2 @Chitosan NCs developed here demonstrate enhanced dispersion stability, biofunctional surface chemistry, and selective antibacterial activity against Gram-positive and Gram-negative strains, positioning them as competitive candidates for biomedical applications. This paper reports for the first time green synthesis of CuO/TiO 2 @Chitosan NCs from M. chamomilla extract, wherein phytochemicals complement chitosan to enhance antibacterial efficacy against multidrug-resistant bacteria. Although M. chamomilla has been used in a few instances in research for metal nanoparticle synthesis and antioxidant studies, its use in a CuO/TiO 2 -chitosan hybrid is novel. This work offers a green protocol and provides a baseline for further optimization and in vivo studies towards biomedical applications.
No takes yet. Share an insight, caveat, or question.
Abumelha et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: